Gene mutations associated with type I endometrial cancer include mutations in tumor suppressor gene PTEN, E-cadherin component β-catenin and K-ras oncogene, while gene mutations in oncogene HER2 and tumor suppressor gene p53 are seen in type II endometrial cancers (Banno et al., 2014). This evidence concerns the gene CDH1 and endometrial cancer.